Evolving DNA repair synthetic lethality targets in cancerSanat Kulkarni, Srinivasan Madhusudan, Emad A. Rakha et al.|Bioscience Reports|2022Cited by 25
PARP inhibitors in ovarian cancer: Mechanisms of resistance and implications to therapySanat Kulkarni, Srinivasan Madhusudan, Çağla Tosun|DNA repair|2025Cited by 20
Targeting DNA damage repair precision medicine strategies in cancerJuliette Brownlie, Srinivasan Madhusudan, Jennie Jeyapalan et al.|Current Opinion in Pharmacology|2023Cited by 19
Towards Personalized Management of Ovarian CancerMashael Algethami, Srinivasan Madhusudan, Sanat Kulkarni et al.|Cancer Management and Research|2022Cited by 18
Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancerSanat Kulkarni, Srinivasan Madhusudan, Ketankumar Gajjar|Frontiers in Oncology|2024Cited by 13